A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis
Clinical trial NCT03218488 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03218488
- Sponsor
- Janssen-Cilag International NV
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2017-10-25
- Primary completion
- 2032-08-31
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.